help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on December 12, 2008, doi:10.1164/rccm.200802-241OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200802-241OCv1
179/5/402    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fell, C. D.
Right arrow Articles by Flaherty, K. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fell, C. D.
Right arrow Articles by Flaherty, K. R.
American Journal of Respiratory and Critical Care Medicine Vol 179. pp. 402-407, (2009)
© 2009 American Thoracic Society
doi: 10.1164/rccm.200802-241OC


Original Article

The Prognostic Value of Cardiopulmonary Exercise Testing in Idiopathic Pulmonary Fibrosis

Charlene D. Fell1, Lyrica Xiaohong Liu2, Caroline Motika3, Ella A. Kazerooni4, Barry H. Gross4, William D. Travis5, Thomas V. Colby6, Susan Murray2, Galen B. Toews7, Fernando J. Martinez7 and Kevin R. Flaherty7

1 Division of Respiratory Medicine, University of Calgary, Calgary, Canada; 2 Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, Michigan; 3 Section of Pulmonary and Critical Care Medicine, University of Chicago, Chicago, Illinois; 4 Department of Radiology, Division of Cardiothoracic Radiology, and 7 Division of Pulmonary and Critical Care Medicine, University of Michigan Health System, Ann Arbor, Michigan; 5 Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York; and 6 Department of Pathology, Mayo Clinic, Scottsdale, Arizona

Correspondence and requests for reprints should be addressed to Kevin R. Flaherty, M.D., M.S., Division of Pulmonary and Critical Care Medicine, University of Michigan Health System, 1500 East Medical Center Drive, 3916 Taubman Center, Ann Arbor, MI 48109. E-mail: flaherty{at}umich.edu

Rationale: Idiopathic pulmonary fibrosis (IPF) is characterized by progressive dyspnea, impaired gas exchange, and ultimate mortality.

Objectives: To test the hypothesis that maximal oxygen uptake during cardiopulmonary exercise testing at baseline and with short-term longitudinal measures would predict mortality in patients with idiopathic pulmonary fibrosis.

Methods: Data from 117 patients with IPF and longitudinal cardiopulmonary exercise tests were examined retrospectively. Survival was calculated from the date of the first cardiopulmonary exercise test.

Measurements and Main Results: Patients with baseline maximal oxygen uptake less than 8.3 ml/kg/min had an increased risk of death (n = 8; hazard ratio, 3.24; 95% confidence interval, 1.10–9.56; P = 0.03) after adjusting for age, gender, smoking status, baseline forced vital capacity, and baseline diffusion capacity for carbon monoxide. We were unable to define a unit change in maximal oxygen uptake that predicted survival in our cohort.

Conclusions: We conclude that a threshold maximal oxygen uptake of 8.3 ml/kg/min during cardiopulmonary exercise testing at baseline adds prognostic information for patients with IPF.

Key Words: idiopathic pulmonary fibrosis • exercise test • mortality


AT A GLANCE COMMENTARY

Scientific Knowledge on the Subject
Prognosis in idiopathic pulmonary fibrosis (IPF) is poor. Predicting prognosis by examining exercise performance with the six-minute-walk test has led to conflicting results.

What This Study Adds to the Field
This study shows that FormulaO2max predicts mortality in patients with IPF. Patients with FormulaO2max less than 8.3 ml/kg/min at baseline had an increased risk of death.

 



This article has been cited by other articles:


Home page
Proc Am Thorac SocHome page
L. B. Ware
Clinical Year in Review I: Interstitial Lung Disease, Pulmonary Vascular Disease, Pulmonary Infections, and Cardiopulmonary Exercise Testing and Pulmonary Rehabilitation
Proceedings of the ATS, September 15, 2009; 6(6): 487 - 493.
[Full Text] [PDF]


Home page
ACCP Pulmonary Med Brd RevHome page
J. P. Lynch III
Idiopathic Pulmonary Fibrosis, Nonspecific Interstitial Pneumonia/Fibrosis, and Sarcoidosis
ACCP Pulmonary Med Brd Rev, January 1, 2009; 25(0): 635 - 686.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2009 American Thoracic Society
  Membership Renewal